+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Prostate Health Market by Product Type, Indication, End User, Distribution Channel, Technology Type - Global Forecast to 2030- Product Image
Prostate Health Market by Product Type, Indication, End User, Distribution Channel, Technology Type - Global Forecast to 2030- Product Image
Sale

Prostate Health Market by Product Type, Indication, End User, Distribution Channel, Technology Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 186 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5639425
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior decision-makers in the life sciences and healthcare sectors are currently facing a significant transformation in the prostate health market. Rapid advancements in diagnostics, therapies, and digital pathology have created new growth avenues, yet ongoing policy shifts and regional complexities continue to shape industry priorities and demand focused strategic action.

Market Snapshot: Prostate Health Market Size and Growth Trends

The prostate health market expanded from USD 57.48 billion in 2024 to USD 63.88 billion in 2025 and is projected to reach USD 106.61 billion by 2030, achieving a CAGR of 10.84%. This sustained growth highlights a strong global focus on advancing prostate health solutions.

Scope & Segmentation

  • Product Types: Diagnostic kits, biopsy devices, imaging agents, PSA tests (conventional and high-sensitivity), chemotherapy, hormone therapies (androgen receptor antagonists, LHRH agonists), immunotherapies, radiopharmaceuticals, imaging systems (computed tomography, magnetic resonance imaging, positron emission tomography, ultrasound—transabdominal and transrectal).
  • Indications: Benign prostatic hyperplasia, prostate cancer, prostatitis.
  • End Users: Ambulatory care centers, diagnostic laboratories, hospitals, specialty clinics.
  • Distribution Channels: Direct tender, hospital pharmacies, online pharmacies, retail pharmacies.
  • Technology Types: Digital pathology (AI-based analysis, whole slide imaging); image analysis software; molecular diagnostics, encompassing biomarker tests (PCA3, TMPRSS2-ERG), next generation sequencing panels, digital PCR, and real-time PCR.
  • Regions: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (key markets), Asia-Pacific (countries such as China, India, Japan, Australia, South Korea, among others).
  • Leading Companies: Astellas Pharma, Pfizer, Johnson & Johnson, Bayer, Novartis, Ferring International Center, Ipsen, AbbVie, AstraZeneca, Merck & Co.

Key Takeaways for Senior Decision-Makers

  • Recent advances in prostate health management—including precision diagnostics and the integration of artificial intelligence in pathology—are facilitating earlier, more accurate disease detection and treatment personalization.
  • Emergent therapies, such as expanded hormone therapy classes and novel radiopharmaceuticals, are broadening therapeutic options for a diverse and shifting patient population.
  • Increased regulatory scrutiny and evolving reimbursement models across regions require organizations to present robust clinical and economic value for successful market access.
  • Strategic collaborations among device manufacturers, diagnostics developers, and pharmaceutical companies are streamlining the launch of integrated solutions and improving competitive differentiation.
  • Regional variations in healthcare infrastructure and regulatory environments drive the need for customized market-entry strategies and the cultivation of local partnerships.
  • Proactive investment in supply chain resilience and local production remains vital to mitigate volatility and ensure ongoing access to advanced prostate health technologies.

Tariff Impact

Recent United States import tariffs have directly influenced the prostate health market, particularly by increasing costs for diagnostic kits and therapeutics sourced internationally. Providers have responded by adjusting procurement channels, seeking alternative supply partnerships, and reassessing inventory strategies to manage margin pressures. Additionally, imaging system vendors are building manufacturing alliances to lower exposure to tariff fluctuations and sustain access to key equipment. These challenges are encouraging a focus on local manufacturing and supply chain innovation to protect growth and maintain patient care standards.

Methodology & Data Sources

This report employs a mixed-methods research design. It synthesizes primary interviews with clinicians and industry experts, in-depth literature reviews, global trade analysis, tariff documentation, company disclosures, and proprietary data. Extensive validation across multiple sources ensures analytical credibility and relevance for strategic decision-making.

Why This Report Matters

  • Enables leadership teams to anticipate evolving market dynamics and make data-driven investment or partnership decisions within the prostate health sector.
  • Informs risk mitigation strategies addressing regulatory shifts and policy-driven cost pressures in both mature and emerging markets.
  • Guides resource allocation by mapping critical opportunities across product innovation, market entry, and competitive positioning against industry peers.

Conclusion

The prostate health market’s ongoing evolution requires senior executives to align with technological advances, respond swiftly to policy changes, and cultivate region-specific strategies. This report offers the insights necessary to navigate complexity, support innovation, and capture lasting competitive advantage in the years ahead.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Prostate Health Market, by Product Type
8.1. Introduction
8.2. Diagnostic Kits
8.2.1. Biopsy Devices
8.2.2. Imaging Agents
8.2.3. Psa Tests
8.2.3.1. Conventional
8.2.3.2. High Sensitivity
8.3. Drugs
8.3.1. Chemotherapy
8.3.2. Hormone Therapy
8.3.2.1. Androgen Receptor Antagonists
8.3.2.2. Lhrh Agonists
8.3.3. Immunotherapy
8.3.4. Radiopharmaceuticals
8.4. Imaging Systems
8.4.1. Computed Tomography
8.4.2. Magnetic Resonance Imaging
8.4.3. Positron Emission Tomography
8.4.4. Ultrasound
8.4.4.1. Transabdominal
8.4.4.2. Transrectal
9. Prostate Health Market, by Indication
9.1. Introduction
9.2. Benign Prostatic Hyperplasia
9.3. Prostate Cancer
9.4. Prostatitis
10. Prostate Health Market, by End User
10.1. Introduction
10.2. Ambulatory Care Centers
10.3. Diagnostic Laboratories
10.4. Hospitals
10.5. Specialty Clinics
11. Prostate Health Market, by Distribution Channel
11.1. Introduction
11.2. Direct Tender
11.3. Hospital Pharmacies
11.4. Online Pharmacies
11.5. Retail Pharmacies
12. Prostate Health Market, by Technology Type
12.1. Introduction
12.2. Digital Pathology
12.2.1. Ai Based Analysis
12.2.2. Whole Slide Imaging
12.3. Image Analysis Software
12.4. Molecular Diagnostics
12.4.1. Biomarker Tests
12.4.1.1. Pca3
12.4.1.2. Tmprss2 Erg
12.4.2. Next Generation Sequencing Panels
12.4.3. Polymerase Chain Reaction Assays
12.4.3.1. Digital Pcr
12.4.3.2. Real Time Pcr
13. Americas Prostate Health Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Prostate Health Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Prostate Health Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Astellas Pharma Inc.
16.3.2. Pfizer Inc.
16.3.3. Johnson & Johnson
16.3.4. Bayer AG
16.3.5. Novartis AG
16.3.6. Ferring International Center S.A.
16.3.7. Ipsen S.A.
16.3.8. AbbVie Inc.
16.3.9. AstraZeneca PLC
16.3.10. Merck & Co., Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. PROSTATE HEALTH MARKET MULTI-CURRENCY
FIGURE 2. PROSTATE HEALTH MARKET MULTI-LANGUAGE
FIGURE 3. PROSTATE HEALTH MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL PROSTATE HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL PROSTATE HEALTH MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PROSTATE HEALTH MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PROSTATE HEALTH MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. PROSTATE HEALTH MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. PROSTATE HEALTH MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. PROSTATE HEALTH MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PROSTATE HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PROSTATE HEALTH MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL PROSTATE HEALTH MARKET SIZE, BY BIOPSY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL PROSTATE HEALTH MARKET SIZE, BY IMAGING AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL PROSTATE HEALTH MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL PROSTATE HEALTH MARKET SIZE, BY HIGH SENSITIVITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL PROSTATE HEALTH MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL PROSTATE HEALTH MARKET SIZE, BY ANDROGEN RECEPTOR ANTAGONISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL PROSTATE HEALTH MARKET SIZE, BY LHRH AGONISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL PROSTATE HEALTH MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL PROSTATE HEALTH MARKET SIZE, BY RADIOPHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL PROSTATE HEALTH MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL PROSTATE HEALTH MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL PROSTATE HEALTH MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL PROSTATE HEALTH MARKET SIZE, BY TRANSABDOMINAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL PROSTATE HEALTH MARKET SIZE, BY TRANSRECTAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL PROSTATE HEALTH MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL PROSTATE HEALTH MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL PROSTATE HEALTH MARKET SIZE, BY PROSTATITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL PROSTATE HEALTH MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL PROSTATE HEALTH MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL PROSTATE HEALTH MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DIRECT TENDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL PROSTATE HEALTH MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL PROSTATE HEALTH MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL PROSTATE HEALTH MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL PROSTATE HEALTH MARKET SIZE, BY AI BASED ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL PROSTATE HEALTH MARKET SIZE, BY WHOLE SLIDE IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL PROSTATE HEALTH MARKET SIZE, BY IMAGE ANALYSIS SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL PROSTATE HEALTH MARKET SIZE, BY PCA3, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL PROSTATE HEALTH MARKET SIZE, BY TMPRSS2 ERG, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL PROSTATE HEALTH MARKET SIZE, BY NEXT GENERATION SEQUENCING PANELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL PROSTATE HEALTH MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL PROSTATE HEALTH MARKET SIZE, BY REAL TIME PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 96. CANADA PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 97. CANADA PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2030 (USD MILLION)
TABLE 98. CANADA PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2030 (USD MILLION)
TABLE 99. CANADA PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 100. CANADA PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, 2018-2030 (USD MILLION)
TABLE 101. CANADA PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 102. CANADA PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 103. CANADA PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 104. CANADA PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. CANADA PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. CANADA PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 107. CANADA PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 108. CANADA PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 109. CANADA PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2030 (USD MILLION)
TABLE 110. CANADA PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, 2018-2030 (USD MILLION)
TABLE 111. MEXICO PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 112. MEXICO PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2030 (USD MILLION)
TABLE 113. MEXICO PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2030 (USD MILLION)
TABLE 114. MEXICO PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 115. MEXICO PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, 2018-2030 (USD MILLION)
TABLE 116. MEXICO PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 117. MEXICO PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 118. MEXICO PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 119. MEXICO PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. MEXICO PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. MEXICO PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 122. MEXICO PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 123. MEXICO PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 124. MEXICO PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2030 (USD MILLION)
TABLE 125. MEXICO PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 149. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 151. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 152. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 153. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 154. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2030 (USD MILLION)
TABLE 155. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 172. UNITED KINGDOM PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2030 (USD MILLION)
TABLE 174. UNITED KINGDOM PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 176. UNITED KINGDOM PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, 2018-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 178. UNITED KINGDOM PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 180. UNITED KINGDOM PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. UNITED KINGDOM PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, 2018-2030 (USD MILLION)
TABLE 187. GERMANY PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 188. GERMANY PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2030 (USD MILLION)
TABLE 189. GERMANY PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2030 (USD MILLION)
TABLE 190. GERMANY PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 191. GERMANY PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, 2018-2030 (USD MILLION)
TABLE 192. GERMANY PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 193. GERMANY PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 194. GERMANY PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 195. GERMANY PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. GERMANY PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 197. GERMANY PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 198. GERMANY PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 199. GERMANY PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 200. GERMANY PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2030 (USD MILLION)
TABLE 201. GERMANY PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, 2018-2030 (USD MILLION)
TABLE 202. FRANCE PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 203. FRANCE PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2030 (USD MILLION)
TABLE 204. FRANCE PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2030 (USD MILLION)
TABLE 205. FRANCE PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 206. FRANCE PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, 2018-2030 (USD MILLION)
TABLE 207. FRANCE PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 208. FRANCE PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 209. FRANCE PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 210. FRANCE PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. FRANCE PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 212. FRANCE PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 213. FRANCE PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 214. FRANCE PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 215. FRANCE PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2030 (USD MILLION)
TABLE 216. FRANCE PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, 2018-2030 (USD MILLION)
TABLE 217. RUSSIA PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 218. RUSSIA PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2030 (USD MILLION)
TABLE 219. RUSSIA PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2030 (USD MILLION)
TABLE 220. RUSSIA PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 221. RUSSIA PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, 2018-2030 (USD MILLION)
TABLE 222. RUSSIA PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 223. RUSSIA PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 224. RUSSIA PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, 2018-2030 (USD MILLION)
TABLE 232. ITALY PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 233. ITALY PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2030 (USD MILLION)
TABLE 234. ITALY PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2030 (USD MILLION)
TABLE 235. ITALY PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 236. ITALY PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, 2018-2030 (USD MILLION)
TABLE 237. ITALY PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 238. ITALY PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 239. ITALY PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 240. ITALY PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. ITALY PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 242. ITALY PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 243. ITALY PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 244. ITALY PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 245. ITALY PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2030 (USD MILLION)
TABLE 246. ITALY PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, 2018-2030 (USD MILLION)
TABLE 247. SPAIN PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 248. SPAIN PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2030 (USD MILLION)
TABLE 249. SPAIN PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2030 (USD MILLION)
TABLE 250. SPAIN PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 251. SPAIN PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, 2018-2030 (USD MILLION)
TABLE 252. SPAIN PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 253. SPAIN PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 254. SPAIN PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 255. SPAIN PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 256. SPAIN PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 257. SPAIN PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 258. SPAIN PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 259. SPAIN PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 260. SPAIN PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2030 (USD MILLION)
TABLE 261. SPAIN PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, 2018-2030 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2030 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2030 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, 2018-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 278. SAUDI ARABIA PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2030 (USD MILLION)
TABLE 280. SAUDI ARABIA PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, 2018-2030 (USD MILLION)
TABLE 282. SAUDI ARABIA PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 283. SAUDI ARABIA PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 284. SAUDI ARABIA PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 285. SAUDI ARABIA PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 286. SAUDI ARABIA PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 287. SAUDI ARABIA PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 288. SAUDI ARABIA PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 289. SAUDI ARABIA PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 290. SAUDI ARABIA PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2030 (USD MILLION)
TABLE 291. SAUDI ARABIA PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, 2018-2030 (USD MILLION)
TABLE 292. SOUTH AFRICA PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 293. SOUTH AFRICA PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2030 (USD MILLION)
TABLE 294. SOUTH AFRICA PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2030 (USD MILLION)
TABLE 295. SOUTH AFRICA PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 296. SOUTH AFRICA PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, 2018-2030 (USD MILLION)
TABLE 297. SOUTH AFRICA PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 298. SOUTH AFRICA PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 299. SOUTH AFRICA PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 300. SOUTH AFRICA PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 301. SOUTH AFRICA PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 302. SOUTH AFRICA PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 303. SOUTH AFRICA PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 304. SOUTH AFRICA PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 305. SOUTH AFRICA PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2030 (USD MILLION)
TABLE 306. SOUTH AFRICA PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, 2018-2030 (USD MILLION)
TABLE 307. DENMARK PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 308. DENMARK PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2030 (USD MILLION)
TABLE 309. DENMARK PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2030 (USD MILLION)
TABLE 310. DENMARK PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 311. DENMARK PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, 2018-2030 (USD MILLION)
TABLE 312. DENMARK PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 313. DENMARK PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 314. DENMARK PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 315. DENMARK PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 316. DENMARK PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 317. DENMARK PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 318. DENMARK PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 319. DENMARK PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 320. DENMARK PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2030 (USD MILLION)
TABLE 321. DENMARK PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, 2018-2030 (USD MILLION)
TABLE 322. NETHERLANDS PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 323. NETHERLANDS PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2030 (USD MILLION)
TABLE 324. NETHERLANDS PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2030 (USD MILLION)
TABLE 325. NETHERLANDS PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 326. NETHERLANDS PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, 2018-2030 (USD MILLION)
TABLE 327. NETHERLANDS PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 328. NETHERLANDS PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 329. NETHERLANDS PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 330. NETHERLANDS PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 331. NETHERLANDS PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 332. NETHERLANDS PROSTATE HEALTH MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 333. NETHERLANDS PROSTATE HEALTH MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 334. NETHERLANDS PROSTATE HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 335. NETHERLANDS PROSTATE HEALTH MARKET SIZE, BY BIOMARKER TESTS, 2018-2030 (USD MILLION)
TABLE 336. NETHERLANDS PROSTATE HEALTH MARKET SIZE, BY POLYMERASE CHAIN REACTION ASSAYS, 2018-2030 (USD MILLION)
TABLE 337. QATAR PROSTATE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 338. QATAR PROSTATE HEALTH MARKET SIZE, BY DIAGNOSTIC KITS, 2018-2030 (USD MILLION)
TABLE 339. QATAR PROSTATE HEALTH MARKET SIZE, BY PSA TESTS, 2018-2030 (USD MILLION)
TABLE 340. QATAR PROSTATE HEALTH MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 341. QATAR PROSTATE HEALTH MARKET SIZE, BY HORMONE THERAPY, 2018-2030 (USD MILLION)
TABLE 342. QATAR PROSTATE HEALTH MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 343. QATAR PROSTATE HEALTH MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 344. QATAR PROSTATE HEALTH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 345. QATAR PROSTATE HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 346. QATAR PROSTATE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Prostate Health market report include:
  • Astellas Pharma Inc.
  • Pfizer Inc.
  • Johnson & Johnson
  • Bayer AG
  • Novartis AG
  • Ferring International Center S.A.
  • Ipsen S.A.
  • AbbVie Inc.
  • AstraZeneca PLC
  • Merck & Co., Inc.

Table Information

Report AttributeDetails
No. of Pages186
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 63.88 Billion
Forecasted Market Value ( USD ) by 2030 $ 106.61 Billion
Compound Annual Growth Rate10.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Prostate Cancer Diagnostics Market by Product Type, Test Type, End User, Technology, Application - Global Forecast to 2030 - Product Image

Prostate Cancer Diagnostics Market by Product Type, Test Type, End User, Technology, Application - Global Forecast to 2030

  • Report
  • 189 Pages
  • Global
From
Prostate Cancer Biomarkers Market Size, Share & Trends Analysis Report by Type (Genetic Biomarkers, Cell-based Biomarkers, Metabolomic Biomarkers), Application, End-use, Region, with Growth Forecasts, 2025-2030 - Product Image

Prostate Cancer Biomarkers Market Size, Share & Trends Analysis Report by Type (Genetic Biomarkers, Cell-based Biomarkers, Metabolomic Biomarkers), Application, End-use, Region, with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Total Prostate Specific Antigen Assay Kit Market by Technology, End Use, Application, Sample Type, Sales Channel - Global Forecast to 2030 - Product Image

Total Prostate Specific Antigen Assay Kit Market by Technology, End Use, Application, Sample Type, Sales Channel - Global Forecast to 2030

  • Report
  • 189 Pages
  • Global
From
Prostate Cancer Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Prostate Cancer Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Prostate Health - Global Strategic Business Report - Product Image

Prostate Health - Global Strategic Business Report

  • Report
  • 463 Pages
  • Global
From

About the Prostate Health Market

The Prostate Health market is a subset of the pharmaceutical industry focused on the development and sale of drugs to treat prostate cancer. Prostate cancer is the most common cancer in men, and the drugs used to treat it are typically hormone therapy, chemotherapy, and radiation therapy. These drugs are used to reduce the size of the tumor, slow its growth, and reduce the risk of metastasis. In addition, some drugs are used to reduce the side effects of prostate cancer treatments, such as fatigue, nausea, and sexual dysfunction. The Prostate Health market is highly competitive, with many companies offering a variety of drugs to treat prostate cancer. Some of the major players in the market include AstraZeneca, Pfizer, Merck, and Johnson & Johnson. Other companies in the market include AbbVie, Bristol-Myers Squibb, and Sanofi. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.